Indications for heart transplantation in pediatric heart disease: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group

Circulation

Volumn 115, Issue 5, 2007, Pages 658-676

  Canter, Charles E ^a   Shaddy, Robert E ^a   Bernstein, Daniel ^a   Hsu, Daphne T ^a   Chrisant, Maryanne R K ^a   Kirklin, James K ^a   Kanter, Kirk R ^a   Higgins, Robert S D ^a   Blume, Elizabeth D ^a   Rosenthal, David N ^a   Boucek, Mark M ^a   Uzark, Karen C ^a   Friedman, Allen H ^a   Young, James K ^a  

^a NONE

Author keywords

AHA Scientific Statements; Pediatrics; Transplantation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; SILDENAFIL;

ARTICLE; CARDIOMYOPATHY; COMORBIDITY; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; HEART DISEASE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFECTION; LUNG VASCULAR RESISTANCE; PEDIATRIC SURGERY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESTRICTIVE CARDIOMYOPATHY; RETRANSPLANTATION; SOCIAL PSYCHOLOGY;

AGE FACTORS; AMERICAN HEART ASSOCIATION; CARDIOLOGY; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SURGICAL PROCEDURES; CHILD; HEALTH PLANNING GUIDELINES; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; NURSING; OUTCOME ASSESSMENT (HEALTH CARE); UNITED STATES;

EID: 33846927773     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.180449     Document Type: Article

References (213)

1. Kantrowitz A, Haller JD, Joos H, Cerruti MM, Carstensen HE. Transplantation of the heart in an infant and an adult. Am J Cardiol. 1968;22:782-790.
2. Pennington DG, Sarafian J, Swartz M. Heart transplantation in children. J Heart Transplant. 1985;4:441-445.
3. Starnes VA, Stinson EB, Oyer PE, Valantine H, Baldwin JC, Hunt SA, Shumway NE. Cardiac transplantation in children and adolescents. Circulation. 1987;76(suppl V):V-43-V-47.
4. Chiavarelli M, Gundry SR, Razzouk AJ, Bailey LL. Cardiac transplantation for infants with hypoplastic left-heart syndrome. JAMA. 1993;270:2944-2947.
5. Backer CL, Zales VR, Harrison HL, Idriss FS, Benson DW Jr, Mavroudis C. Intermediate term results of infant orthotopic cardiac transplantation from two centers. J Thorac Cardiovasc Surg. 1991;101:826-832.
6. Mahle WT, Spray TL, Wernovsky G, Gaynor JW, Clark BJ III. Survival after reconstructive surgery for hypoplastic left heart syndrome: a 15-year experience from a single institution. Circulation. 2000;102(suppl III):III-136-III-141.
7. Tweddell JS, Hoffman GM, Mussatto KA, Fedderly RT, Berger S, Jaquiss RD, Ghanayem NS, Frisbee SJ, Litwin SB. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation. 2002;106(suppl I):I-82-I-89.
8. Azakie T, Merklinger SL, McCrindle BW, Van Arsdell GS, Lee KJ, Benson LN, Coles JG, Williams WG. Evolving strategies and improving outcomes of the modified Norwood procedure: a 10-year single-institution experience. Ann Thorac Surg. 2001;72:1349-1353.
9. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: eighth official pediatric report - 2005. J Heart Lung Transplant. 2005;24:968-982.
10. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, Ritsch ME Jr, Stevenson LW. 24th Bethesda conference: cardiac transplantation: Task Force 3: recipient guidelines/prioritization. J Am Coll Cardiol. 1993;22:21-31.
11. Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell JB, Driscoll D, Rose E. Selection and treatment of candidates for heart transplantation: a statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1995;92:3593-3612.
12. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Deng MC, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report - 2005. J Heart Lung Transplant. 2005;24:945-955.
13. Bruns LA, Chrisant MK, Lamour JM, Shaddy RE, Pahl E, Blume ED, Hallowell S, Addonizio LJ, Canter CE. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr. 2001;138:505-511.
14. Azeka E, Franchini Ramires JA, Valler C, Alcides Bocchi E. Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. J Am Coll Cardiol. 2002;40:2034-2038.
15. Chen JM, Davies RR, Mital SR, Mercando ML, Addonizio LJ, Pinney SP, Hsu DT, Lamour JM, Quaegebeur JM, Mosca RS. Trends and outcomes in transplantation for complex congenital heart disease: 1984 to 2004. Ann Thorac Surg. 2004;78:1352-1361.
16. Marelli D, Laks H, Kobashigawa JA, Bresson J, Ardehali A, Esmailian F, Plunkett MD, Kubak B. Seventeen-year experience with 1,083 heart transplants at a single institution. Ann Thorac Surg. 2002;74:1558-1566.
17. Pigula FA, Gandhi SK, Ristich J, Stukus D, McCurry K, Webber SA, Keenan R, Griffith BP, Kormos R. Cardiopulmonary transplantation for congenital heart disease in the adult. J Heart Lung Transplant. 2001;20:297-303.
18. Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, McCoy KL, McDonald MA, Messere JE, Colan SD. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647-1655.
19. Nugent AW, Daubeney PEF, Chondros P, Carlin JB, Cheung M, Wilkinson LC, Davis AM, Kahler SG, Chow CW, Wilkinson JL, Weintraub RG; National Australian Childhood Cardiomyopathy Study. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639-1646.
20. Canter CE, Naftel DC. Recipient characteristics. In Pediatric Solid Organ Transplantation. 2nd ed. Fine R, Webber S, Harmon W, Olthoff K, Kelly D, eds. Malden, Mass: Blackwell; 2007:chap 31.
21. Taliercio CP, Seward JB, Driscoll DJ, Fisher LD, Gersh BJ, Tajik AJ. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol. 1985;6:1126-1131.
22. Griffin ML, Hernandez A, Martin TC, Goldring D, Bolman RM, Spray TL, Strauss AW. Dilated cardiomyopathy in infants and children. J Am Coll Cardiol. 1988;11:139-144.
23. Chen SC, Nouri S, Balfour I, Jureidini S, Appleton RS. Clinical profile of congestive cardiomyopathy in children. J Am Coll Cardiol. 1990;15:189-193.
24. Lewis AB, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol. 1991;68:365-369.
25. Akagi T, Benson LN, Lightfoot NE, Chin K, Wilson G, Freedom RM. Natural history of dilated cardiomyopathy in children. Am Heart J. 1991;121:1502-1506.
26. Tsirka AE, Trinkaus K, Chen SC, Lipshultz SE, Towbin JA, Colan SD, Exil V, Strauss AW, Canter CE. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol. 2004;44:391-397.
27. Wiles HB, McArthur PD, Taylor AB, Gillette PC, Fyfe DA, Matthews JP, Shelton LW. Prognostic features of children with idiopathic dilated cardiomyopathy. Am J Cardiol. 1991;68:1372-1376.
28. Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE. Dilated cardiomyopathy in children: determinants of outcome. Br Heart J. 1994;72:246-250.
29. Matitiau A, Perez-Atayde A, Sanders SP, Sluysmans T, Parness IA, Spevak PJ, Colan SD. Infantile dilated cardiomyopathy: relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation. 1994;90:1310-1318.
30. Arola A, Jokinen E, Ruuskanen O, Saraste M, Pesonen E, Kuusela AL, Tikanoja T, Paavilainen T, Simell O. Epidemiology of idiopathic cardiomyopathies in children and adolescents: a nationwide study in Finland. Am J Epidemiol. 1997;146:385-393.
31. Lewis AB. Late recovery of ventricular function in children with idiopathic dilated cardiomyopathy. Am Heart J. 1999;138:334-338.
32. Lewis AB. Prognostic value of echocardiography in children with idiopathic dilated cardiomyopathy. Am Heart J. 1994;128:133-136.
33. Kimball TR, Daniels SR, Meyer RA, Schwartz DC, Kaplan S. Left ventricular mass in childhood dilated cardiomyopathy: a possible predictor for selection of patients for cardiac transplantation. Am Heart J. 1991;122(pt 1):126-131.
34. Redfield MM, Gersh BJ, Bailey KR, Rodeheffer RJ. Natural history of incidentally discovered, asymptomatic idiopathic dilated cardiomyopathy. Am J Cardiol. 1994;74:737-739.
35. Calabrese F, Rigo E, Milanesi O, Boffa GM, Angelini A, Valente M, Thiene G. Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol. 2002;11:212-221.
36. Lee KJ, McCrindle BW, Bohn DJ, Wilson GJ, Taylor GP, Freedom RM, Smallhorn JF, Benson LN. Clinical outcomes of acute myocarditis in childhood. Heart. 1999;82:226-233.
37. English RF, Janosky JE, Ettedgui JA, Webber SA. Outcomes for children with acute myocarditis. Cardiol Young. 2004;14:488-493.
38. McCarthy RE III, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcomes of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000;342:690-695.
39. Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg. 2001;122:440-448.
40. Duncan BW. Mechanical circulatory support for infants and children with cardiac disease. Ann Thorac Surg. 2002;73:1670-1677.
41. Stiller B, Dahnert I, Weng YG, Hennig E, Hetzer R, Lange PE. Children may survive severe myocarditis with prolonged use of biventricular assist devices. Heart. 1999;82:237-240.
42. Lipshultz SE, Orav EJ, Towbin JA, Messere J, Iadarola S, Cuniberti L, Lowe AM, Clunie S, Cox GF, Lurie PR, Canter C, Hsu D, Morrow WR, Colan SD. Outcome predictors in pediatric hypertrophic cardiomyopathy. Circulation. 2004; 110(suppl III):III-442. Abstract.
43. Nugent AW, Daubeney PE, Chondros P, Carlin JB, Colan SD, Cheung M, Davis AM, Chow CW, Weintraub RG; National Australian Childhood Cardiomyopathy Study. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation. 2005;112:1332-1338.
44. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 1996;93:841-842.
45. Kimberling MT, Balzer DT, Hirsch R, Mendeloff E, Huddleston CB, Canter CE. Cardiac transplantation for pediatric restrictive cardiomyopathy: presentation, evaluation, and short-term outcome. J Heart Lung Transplant. 2002;21:455-459.
46. Weller RJ, Weintraub R, Addonizio LJ, Chrisant MR, Gersony WM, Hsu DT. Outcome of idiopathic restrictive cardiomyopathy in children. Am J Cardiol. 2002;90:501-506.
47. Russo LM, Webber SA. Idiopathic restrictive cardiomyopathy in children. Heart. 2005;91:1199-1202.
48. Pinamonti B, Zecchin M, Di Lenarda A, Gregori D, Sinagra G, Camerini F. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol. 1997;29:604-612.
49. Angelini A, Calzolari V, Thiene G, Boffa GM, Valente M, Daliento L, Basso C, Calabrese F, Razzolini R, Livi U, Chioin R. Morphologic spectrum of primary restrictive cardiomyopathy. Am J Cardiol. 1997;80:1046-1050.
50. Denfield SW, Rosenthal G, Gajarski RJ, Bricker JT, Schowengerdt KO, Price JK, Towbin JA. Restrictive cardiomyopathies in childhood: etiologies and natural history. Tex Heart Inst J. 1997;24:38-44.
51. Cetta F, O'Leary PW, Seward JB, Driscoll DJ. Idiopathic restrictive cardiomyopathy in childhood: diagnostic features and clinical course. Mayo Clin Proc. 1995;70:634-640.
52. Rivenes SM, Kearney DL, Smith EO, Towbin JA, Denfield SW. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation. 2000;102:876-882.
53. Nugent A, Daubeney P, Chondros P, Cheung M, Davis A, Carlin J, Weintraub R. The natural history of restrictive cardiomyopathy presenting during childhood. J Am Coll Cardiol. 2002;39(suppl A):144A. Abstract.
54. Rychik J, Levy H, Gaynor JW, DeCampli WM, Spray TL. Outcome after operations for pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg. 1998;116:924-931.
55. Ashburn DA, Blackstone EH, Wells WJ, Jonas RA, Pigula FA, Manning PB, Lofland GK, Williams WG, McCrindle BW; Congenital Heart Surgeons Study members. Determinants of mortality and type of repair in neonates with pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg. 2004;127:1000-1008.
56. Larsen RL, Eguchi JH, Mulla NF, Johnston JK, Fitts J, Kuhn MA, Razzouk AJ, Chinnock RE, Bailey LL. Usefulness of cardiac transplantation in children with visceral heterotaxy (asplenic and polysplenic syndromes and single right-sided spleen with levocardia) and comparison of results with cardiac transplantation in children with dilated cardiomyopathy. Am J Cardiol. 2002;89:1275-1279.
57. Lim JSL, McCrindle BW, Smallhorn JF, Golding F, Caldarone CA, Taketazu M, Jaeggi ET. Clinical features, management, and outcome of children with fetal and postnatal diagnoses of isomerism syndromes. Circulation. 2005;112:2454-2461.
58. Jacobs ML, Blackstone EH, Bailey LL; the Congenital Heart Surgeons Society. Intermediate survival in neonates with aortic atresia: a multi-institutional study. J Thorac Cardiovasc Surg. 1998;116:417-431.
59. Jenkins PC, Flanagan MF, Jenkins KJ, Sargent JD, Canter CE, Chinnock RE, Vincent RN, Tosteson AN, O'Connor GT. Survival analysis and risk factors for mortality in transplantation and staged surgery for hypoplastic left heart syndrome. J Am Coll Cardiol. 2000;36:1178-1185.
60. Jenkins PC, Flanagan MF, Sargent JD, Canter CE, Chinnock RE, Jenkins KJ, Vincent RN, O'Connor GT, Tosteson AN. A comparison of treatment strategies for hypoplastic left heart syndrome using decision analysis. J Am Coll Cardiol. 2001;38:1181-1187.
61. Morrow R, Naftel D, Chinnock R, Canter C, Boucek M, Zales V, McGiffen D, Kirklin JK; the Pediatric Heart Transplantation Study Group. Outcome of listing for cardiac transplantation in infants younger than six months: predictors of death and interval to transplantation. J Heart Lung Transplant. 1997;16:1255-1266.
62. Organ Procurement and Transplant Network (OPTN) World Wide Web site. Available at: http://www.OPTN.org. Accessed January 15, 2006.
63. Chrisant MRK, Naftel DC, Drummond-Webb J, Chinnock R, Canter CE, Boucek MM, Boucek RJ, Hallowell SC, Kirklin JK, Morrow WR; Pediatric Heart Transplant Study Group. Fate of infants with hypoplastic left heart syndrome listed for cardiac transplantation: a multicenter study. J Heart Lung Transplant. 2005;24:576-582.
64. Webb GD, Williams RG. Proceedings of the 32nd Bethesda Conference: Care of the adult with congenital heart disease. J Am Coll Cardiol. 2001;37:1166-1198.
65. Warnes CA. The adult with congenital heart disease: born to be bad? J Am Coll Cardiol. 2005;46:1-8.
66. Lamour JM, Kanter KR, Naftel DC, Chrisant MR, Morrow WR, Clemson BS, Kirklin JK. The effect of age, diagnosis and previous surgery in 488 children and adults who undergo heart transplantation for congenital heart disease. J Am Coll Cardiol. 2005;45:322A. Abstract.
67. Fontan F, Kirklin JW, Fernandez G, Costa F, Naftel DC, Tritto F, Blackstone EH. Outcome after a "perfect" Fontan operation. Circulation. 1990;81:1520-1536.
68. Gentles TL, Gauvreau K, Mayer JE Jr, Fishberger SB, Burnett J, Colan SD, Newburger JW, Wernovsky G. Functional outcome after the Fontan operation: factors influencing late morbidity. J Thorac Cardiovasc Surg. 1997;114:392-403.
69. Driscoll DJ, Offord KP, Feldt RH, Schaff HV, Puga FJ, Danielson GK. Five- to fifteen-year follow-up after Fontan operation. Circulation. 1992;85:469-496.
70. Harrison DA, Liu P, Walters JE, Goodman JM, Siu SC, Webb GD, Williams WG, McLaughlin PR. Cardiopulmonary function in adult patients late after Fontan repair. J Am Coll Cardiol. 1995;26:1016-1021.
71. Gelatt M, Hamilton RM, McCrindle BW, Connelly M, Davis A, Harris L, Gow RM, Williams WG, Trusler GA, Freedom RM. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol. 1997;29:194-201.
72. Birnie D, Tometzki A, Curzio J, Houston A, Hood S, Swan L, Doig W, Wilson N, Jamieson M, Pollock J, Hillis WS. Outcomes of transposition of the great arteries in the era of atrial inflow correction. Heart. 1998;80:170-173.
73. Graham TP Jr, Bernard YD, Mellen BH, Celermajer D, Baumgartner H, Cetta F, Connolly HM, Davidson WR, Dellborg M, Foster E, Gersony WM, Gessner IH, Hurwitz RA, Kaemmerer H, Kugler JD, Murphy DJ, Noonan JA, Morris C, Perloff JK, Sanders SP, Sutherland JL. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol. 2000;36:255-261.
74. Hsu DT, Quaegebeur JM, Michler RE, Smith CR, Rose EA, Kichuk MR, Gersony WM, Douglas JF, Addonizio LJ. Heart transplantation in children with congenital heart disease. J Am Coll Cardiol. 1995;26:743-749.
75. Perrault H, Drblik SP, Montigny M, Davignon A, Lamarre A, Chartrand C, Stanley P. Comparison of cardiovascular adjustments to exercise in adolescents 8 to 15 years of age after correction of tetralogy of Fallot, ventricular septal defect or atrial septal defect. Am J Cardiol. 1989;64:213-217.
76. Paridon SM. Congenital heart disease: cardiac performance and adaptations to exercise. Pediatr Exerc Sci. 1997;9:308-323.
77. Reybrouck T, Mertens L, Brusselle S, Weymans M, Eyskens B, Defoor J, Gewillig M. Oxygen uptake versus exercise intensity: a new concept in assessing cardiovascular exercise function in patients with congenital heart disease. Heart. 2000;84:46-52.
78. Fredriksen PM, Veldtman G, Hechter S, Therrien J, Chen A, Warsi MA, Freeman M, Liu P, Siu S, Thaulow E, Webb G. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol. 2001;87:310-314.
79. 2peak between patients with congenital heart disease and healthy subjects, all aged 8-17 years. Eur J Appl Physiol Occup Physiol. 1999;80:409-416.
80. Zellers TM, Driscoll DJ, Mottram CD, Puga FJ, Schaff HV, Danielson GK. Exercise tolerance and cardiorespiratory response to exercise before and after the Fontan operation. Mayo Clin Proc. 1989;64:1489-1497.
81. Gewillig MH, Lundström UR, Bull C, Wyse RK, Deanfield JE. Exercise responses in patients with congenital heart disease after Fontan repair: patterns and determinants of performance. J Am Coll Cardiol. 1990;15:1424-1432.
82. Saliba Z, Butera G, Bonnet D, Bonhoeffer P, Villain E, Kachaner J, Sidi D, Iserin L. Quality of life and perceived health status in surviving adults with univentricular heart. Heart. 2001;86:69-73.
83. Kamphuis M, Ottenkamp J, Vliegen HW, Vogels T, Zwinderman KH, Kamphuis RP, Verloove-Vanhorick SP. Health related quality of life and health status in adult survivors with previously operated complex congenital heart disease. Heart. 2002;87:356-362.
84. Hager A, Hess J. Comparison of health related quality of life with cardiopulmonary exercise testing in adolescents and adults with congenital heart disease. Heart. 2005;91:517-520.
85. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in adult congenital heart disease. Comparative severity, correlates, and prognostic implication. Circulation. 2005;112:828-835.
86. Feldt RH, Driscoll DJ, Offord KP, Cha RH, Perrault J, Schaff HV, Puga FJ, Danielson GK. Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg. 1996;112:672-680.
87. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M; PLE Study Group. Protein-losing enteropathy after the Fontan operation: an international multicenter study. J Thorac Cardiovasc Surg. 1998;115:1063-1073.
88. Mertens LL, Hagler DJ, Canter CE, Goldberg SJ, Parisi F, Pahl E, Wilkinson J, Gewillig M. The outcome of heart transplantation for protein-losing enteropathy after the Fontan operation. Circulation. 1999;100(suppl II):II-602. Abstract.
89. Bernstein D, Naftel D, Chin C, Addonizio L, Gamberg P, Blume ED, Hsu D, Canter CE, Kirklin JK, Morrow WR; Pediatric Heart Disease Study. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006;114:273-280.
90. Michler RE, Edwards NM, Hsu D, Bernstein D, Fricker FJ, Miller J, Copeland J, Kaye MP, Addonizio L. Pediatric retransplantation. J Heart Lung Transplant. 1993;12(pt 2):S319-S327.
91. Dearani JA, Razzouk AJ, Gundry SR, Chinnock RE, Larsen RL, del Rio MJ, Johnston JK, Bailey LL. Pediatric cardiac retransplantation: intermediate-term results. Ann Thorac Surg. 2001;71:66-70.
92. Kanter KR, Vincent RN, Berg AM, Mahle WT, Forbess JM, Kirshbom PM. Cardiac retransplantation in children. Ann Thorac Surg. 2004;78:644-649.
93. Braunlin EA, Hunter DW, Canter CE, Gutierrez FR, Ring WS, Olivari MT, Titus JL, Spray TL, Bolman RM III. Coronary artery disease in pediatric cardiac transplant recipients receiving triple-drug immunosuppression. Circulation. 1991;84(suppl):III-303-III-309.
94. Pahl E, Naftel DC, Kuhn MA, Shaddy RE, Morrow WR, Canter CE, Kirklin J; Pediatric Heart Transplant Study. The impact and outcome of transplant coronary artery disease in a pediatric population: a 9-year multi-institutional study. J Heart Lung Transplant. 2005;24:645-651.
95. Mahle WT, Vincent RN, Kanter KR. Cardiac retransplantation in childhood: analysis of data from the United Network for Organ Sharing. J Thorac Cardiovasc Surg. 2005;130:542-546.
96. Almond CS, Blume ED, Edwards LB, Boucek MM. Risk factors for mortality following pediatric heart retransplantation: analysis from the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant. 2006;25:S51-S52. Abstract.
97. Chin C, Naftel D, Pahl E, Shankel T, Clark ML, Gamberg P, Kirklin J, Webber S. Cardiac retransplantation in pediatrics: a multi-institutional study. J Heart Lung Transplant. 2006;25:S52. Abstract.
98. Smith JA, Ribakove GH, Hunt SA, Miller J, Stinson EB, Oyer PE, Robbins RC, Shumway NE, Rietz BA. Heart retransplantation: the 25-year experience at a single institution. J Heart Lung Transplant. 1995;14:832-839.
99. Schnetzler B, Pavie A, Dorent R, Camproux AC, Leger P, Delcourt A, Gandjbakhch I. Heart retransplantation: a 23-year single-center clinical experience. Ann Thorac Surg. 1998;65:978-983.
100. John R, Chen JM, Weinberg A, Oz MC, Mancini D, Itescu S, Galantowicz ME, Smith CR, Rose EA, Edwards NM. Long-term survival after cardiac retransplantation: a twenty-year single-center experience. J Thorac Cardiovasc Surg. 1999;117:543-555.
101. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: summary article. J Am Coll Cardiol. 2005;46:1116-1143.
102. Ross RD, Bollinger RO, Pinsky WW. Grading the severity of congestive heart failure in infants. Pediatr Cardiol. 1992;13:72-75.
103. Connolly D, Rutkowski M, Auslender M, Artman M. The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children. J Pediatr. 2001;138:644-648.
104. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001;38:2101-2113.
105. Rosenthal D, Chrisant MR, Edens E, Mahony L, Canter C, Colan S, Dubin A, Lamour J, Ross R, Shaddy R, Addonizio L, Beerman L, Berger S, Bernstein D, Blume E, Boucek M, Checchia P, Dipchand A, Drummond-Webb J, Fricker J, Friedman R, Hallowell S, Jaquiss R, Mital S, Pahl E, Pearce B, Rhodes L, Rotondo K, Rusconi P, Scheel J, Singh TP, Towbin J. International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children. J Heart Lung Transplant. 2004;23:1313-1333.
106. Todaro JF, Fennell EB, Sears SF, Rodrigue JR, Roche AK. Review: cognitive and psychological outcomes in pediatric heart transplantation. J Pediatr Psych. 2000;25:567-576.
107. Baum M, Freier MC, Freeman K, Babikian T, Ashwal S, Chinnock R, Bailey L. Neuropsychological outcome of infant heart transplant recipients. J Pediatr. 2004;145:365-372.
108. DeMaso DR, Kelley SD, Bastardi H, O'Brien P, Blume ED. The longitudinal impact of psychological functioning, medical severity, and family functioning in pediatric heart transplantation. J Heart Lung Transplant. 2004;23:473-480.
109. Wray J, Radley-Smith R. Beyond the first year after pediatric heart or heart-lung transplantation: changes in cognitive function and behaviour. Pediatr Transplant. 2005;9:170-177.
110. Renlund DG, Taylor DO, Kfoury AG, Shaddy RS. New UNOS rules: historical background and implications for transplantation management: United Network for Organ Sharing. J Heart Lung Transplant. 1999;18:1065-1070.
111. Rosenthal DN, Dubin AM, Chin C, Falco D, Gamberg P, Bernstein D. Outcome while awaiting heart transplantation in children: a comparison of congenital heart disease and cardiomyopathy. J Heart Lung Transplant. 2000;19:751-755.
112. Mital S, Addonizio LJ, Lamour JM, Hsu DT. Outcome of children with end-stage congenital heart disease waiting for cardiac transplantation. J Heart Lung Transplant. 2003;22:147-153.
113. Addonizio LJ, Zangwill SD, Rosenthal DN, Naftel C, Korsin R, Hsu DT, Kirklin JK. Have changes in UNOS status system improved allocation in pediatric heart recipients? J Heart Lung Transplant. 2005;24:S64-S65. Abstract.
114. Kirklin JK, Naftel DC, Caldwell RL, Pearce FB, Bartlett H, Rusconi P, White-Williams C, Robinson BV. Should status II patients be removed from the pediatric heart transplant waiting list? A multi-institutional study. J Heart Lung Transplant. 2006;25:271-275.
115. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmonds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778-786.
116. Kao W, Jessup M. Exercise testing and exercise training in patients with congestive heart failure. J Heart Lung Transplant. 1994;13:S117-S121.
117. Aaronson KD, Mancini DM. Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure? (published correction appears in J Heart Lung Transplant. 1996;15(pt 1):106 -107) J Heart Lung Transplant. 1995;14:981-989.
118. Stelken AM, Younis LT, Jennison SH, Miller DD, Miller LW, Shaw LJ, Kargl D, Chaitman BR. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol. 1996;27:345-352.
119. O'Neill JO, Young JB, Pothier CE, Lauer MS. Peak oxygen consumption as a predictor of death in patients with heart failure receiving β-blockers. Circulation. 2005;111:2313-2318.
120. Chomsky DB, Lang CC, Rayos GH, Shyr Y, Yeoh TK, Pierson RN III, Davis SF, Wilson JR. Hemodynamic exercise testing: a valuable tool in the selection of cardiac transplantation candidates. Circulation. 1996;94:3176-3183.
121. Ponikowski P, Francis DP, Piepoli MF, Davies LC, Chua TP, Davos CH, Florea V, Banasiak W, Poole-Wilson PA, Coats AJ, Anker SD. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation. 2001;103:967-972.
122. Miller LW. Listing criteria for cardiac transplantation: results of an American Society of Transplant Physicians-National Institutes of Health conference. Transplantation. 1998;66:947-951.
123. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660-2667.
124. Butler J, Khadim G, Paul KM, Davis SF, Kronenberg MW, Chomsky DB, Pierson RN III, Wilson JR. Selection of patients for heart transplantation in the current era of heart failure therapy. J Am Coll Cardiol. 2004;43:787-793.
125. Washington RL, van Gundy JC, Cohen C, Sondheimer HM, Wolfe RR. Normal aerobic and anaerobic exercise data in North American school-age children. J Pediatr. 1988;112:223-233.
126. Braden DS, Carroll JF. Normative cardiovascular responses to exercise in children. Pediatr Cardiol. 1999;20:4-10
127. Sanghavi DM, Flanagan M, Powell AJ, Curran T, Picard S, Rhodes J. Determinants of exercise function following univentricular versus biventricular repair for pulmonary atresia/intact ventricular septum. Am J Cardiol. 2006;97:1638-1643.
128. Ohuchi H, Yasuda K, Hasegawa S, Miyazaki A, Takamuro M, Yamada O, Ono Y, Uemura H, Yagihara T, Echigo S. Influence of ventricular morphology on aerobic exercise capacity after the Fontan operation. J Am Coll Cardiol. 2001;37:1967-1974.
129. Paridon SM, Mitchell PD, Blaufox A, Gallagher D, Li J, Mital S, Russell J, Williams RV, Rhodes J. A cross-sectional study of exercise performance during the first two decades of life following the Fontan procedure. Circulation. 2004;110(suppl III):III-386. Abstract.
130. Mahle WT, Wernovsky G, Bridges ND, Linton AB, Paridon SM. Impact of early ventricular unloading on exercise performance in preadolescents with single ventricle Fontan physiology. J Am Coll Cardiol. 1999;34:1637-1643.
131. Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol. 2000;36:1587-1593.
132. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, von Scheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol. 2001;38:1934-1941.
133. Stanek B, Frey B, Hülsmann M, Berger R, Sturm B, Strametz-Juranek J, Bergler-Klein J, Moser P, Bojic A, Hartter E, Pacher R. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol. 2001;38:436-442.
134. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, Pacher R. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002;105:2392-2397.
135. Tang WH, Girod JP, Lee MJ, Starling RC, Young JB, Van Lente F, Francis GS. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation. 2003;108:2964-2966.
136. De Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol. 2004;43:1584-1589.
137. Law YM, Keller BB, Feingold BM, Boyle GJ. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol. 2005;95:474-478.
138. Lin NC, Landt ML, Trinkaus KM, Balzer DT, Kort HW, Canter CE. Relationship of age, severity of illness, and hemodynamics with brain natriuretic peptide levels in patients <20 years of age with heart disease. Am J Cardiol. 2005;96:847-850.
139. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, Coats AJ, Anker SD, Gatzoulis MA. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 2002;106:92-99.
140. Ohuchi H, Takasugi H, Ohashi H, Okada Y, Yamada O, Ono Y, Yagihara T, Echigo S. Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation. 2003;108:2368-2376.
141. Koch A, Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart. 2003;89:875-878.
142. Sun LS, Dominguez C, Mallavaram NA, Quaegebeur JM. Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular hearts. J Thorac Cardiovasc Surg. 2005;129:1104-1110.
143. Ross RD. Medical management of chronic heart failure in children. Am J Cardiovasc Drugs. 2001;1:37-44.
144. Schwartz SM, Gewitz MH, See CC, Berezin S, Glassman MS, Medow CM, Fish BC, Newman LJ. Enteral nutrition in infants with congenital heart disease and growth failure. Pediatrics. 1990;86:368-373.
145. Leitch CA. Growth, nutrition and energy expenditure in pediatric heart failure. Prog Pediatr Cardiol. 2000;11:195-202.
146. Cohen A, Addonizio LJ, Softness B, Lamour JM, McMahon DJ, Addesso V, Diamond BE, Shane E. Growth and skeletal maturation after pediatric heart transplantation. Pediatr Transplant. 2004;8:126-135.
147. De Broux E, Huot CH, Chartrand S, Vobecky S, Chartrand C. Growth and pubertal development following pediatric heart transplantation: a 15-year experience at Ste-Justine Hospital. J Heart Lung Transplant. 2000;19:825-833.
148. Hirsch R, Huddleston CB, Mendeloff EN, Sekarski TJ, Canter CE. Infant and donor organ growth after heart transplantation in neonates with hypoplastic left heart syndrome. J Heart Lung Transplant. 1996;15:1093-1100.
149. Chinnock RE, Cutler D, Baum M. Clinical outcome 10 years after infant heart transplantation. Prog Pediatr Cardiol. 2000;11:165-169.
150. Chatrath R, Porter CB, Ackerman MJ. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. Mayo Clin Proc. 2002;77:226-231.
151. Stefanelli CB, Bradley DJ, Leroy S, Dick M II, Serwer GA, Fischbach PS. Implantable cardioverter-defibrillator therapy for life-threatening arrhythmias in young patients. J Interv Card Electrophysiol. 2002;6:235-244.
152. Berul CI, Triedman JK, Forbess J, Bevilacqua LM, Alexander ME, Dahlby D, Gilkerson JO, Walsh EP. Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report. Pacing Clin Electrophysiol. 2001;24:1789-1794.
153. Gradaus R, Hammel D, Kotthoff S, Bocker D. Nonthoracotomy implantable cardioverter defibrillator placement in children: use of subcutaneous array leads and abdominally placed implantable cardioverter defibrillators in children. J Cardiovasc Electrophysiol. 2001;12:356-360.
154. Rhee EK, Canter CE, Basile S, Naftel DC. Sudden cardiac death prior to pediatric heart transplantation: would implantable defibrillators improve outcome? J Heart Lung Transplant. 2005;24:S63. Abstract.
155. Canter CE. Preoperative assessment and management of pediatric heart transplantation. Prog Pediatr Cardiol. 2000;11:91-97.
156. Shaddy RE, Fuller TC. The sensitized pediatric heart transplant candidate: causes, consequences, and treatment options. Pediatr Transplant. 2005;9:208-214.
157. Cimato TR, Jessup M. Recipient selection in cardiac transplantation: contraindications and risk factors for mortality. J Heart Lung Transplant. 2002;21:1161-1173.
158. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349:931-940.
159. Leeser DB, Jeevanandam V, Furukawa S, Eisen H, Mather P, Silva P, Guy S, Foster CE III. Simultaneous heart and kidney transplantation in patients with end-stage heart and renal failure. Am J Transplant. 2001;1:89-92.
160. Vermes E, Kirsch M, Houël R, Legouvelo S, Benvenuti C, Aptecar E, Le Besnerais P, Lang P, Abbou C, Loisance D. Immunologic events and long-term survival after combined heart and kidney transplantation: a 12-year single-center experience. J Heart Lung Transplant. 2001;20:1084-1091.
161. Porrett PM, Desai SS, Timmins KJ, Twomey CR, Sonnad SS, Olthoff KM. Combined orthotopic heart and liver transplantation: the need for exception status listing. Liver Transplant. 2004;10:1539-1544.
162. Finsterer J, Bittner RE, Grimm M. Cardiac involvement in Becker's muscular dystrophy, necessitating heart transplantation, 6 years before apparent skeletal muscle involvement. Neuromuscul Disord. 1999;9:598-600.
163. Piccolo G, Azan G, Tonin P, Arbustini E, Gavazzi A, Banfi P, Mora M, Morandi L, Tedeschi S. Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy. Neuromuscul Disord. 1994;4:143-146.
164. Quinlivan RM, Dubowitz V. Cardiac transplantation in Becker muscular dystrophy. Neuromuscul Disord. 1992;2:165-167.
165. Goldstein DJ, Seldomridge JA, Addonizio LL, Rose EA, Oz MC, Michler RE. Orthotopic heart transplantation in patients with treated malignancies. Am J Cardiol. 1995;75:968-971.
166. Ward KM, Binns H, Chin C, Webber SA, Canter CE, Pahl E. Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare. J Heart Lung Transplant. 2004;23:1040-1045.
167. Kocher AA, Ankersmit J, Khazen C, Ofner P, Zuckermann A, Grimm M, Schlechta B, Ehrlich M, Wolner E, Laufer G. Effect of obesity on outcome after cardiac transplantation (published correction appears in Transplant Proc. 2000;32:503). Transplant Proc. 1999;31:3187-3189.
168. Grady KL, White-Williams C, Naftel D, Costanzo MR, Pitts D, Rayburn B, VanBakel A, Jaski B, Bourge R, Kirklin J; Cardiac Transplant Research Database (CTRD) Group. Are preoperative obesity and cachexia risk factors for post heart transplant morbidity and mortality: a multi-institutional study of preoperative weight-height indices. J Heart Lung Transplant. 1999;18:750-763.
169. Baker AM, Levine TB, Goldberg AD, Levine AB. Natural history and predictors of obesity after orthotopic heart transplantation. J Heart Lung Transplant. 1992;11:1156-1159.
170. Ibrahim J, Canter CE, Chinnock RE, Kirklin JK, Naftel DC, Basile S, West L. Linear and somatic growth following pediatric heart transplantation. J Heart Lung Transplant. 2002;21:63. Abstract.
171. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation. 2003;107:1448-1453.
172. Hosenpud JD, Pamidi SR, Fiol BS, Cinquegrani MP, Keck BM. Outcomes in patients who are hepatitis B surface antigen-positive before transplantation; an analysis and study using the joint ISHLT/UNOS thoracic registry. J Heart Lung Transplant. 2000;19:781-785.
173. Ko WJ, Chou NK, Hsu RB, Chen YS, Wang SS, Chu SH, Lai MY. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area. J Heart Lung Transplant. 2001;20:865-875.
174. Lake KD, Smith CI, Milfred-La Forest SK, Pritzker MR, Emery RW. Outcome of hepatitis C positive (HCV+) heart transplant recipients. Transplantation Proc. 1997;29:581-582.
175. Lake KD, Smith CI, Pritzker MR, Renlund DE, Heilman JK, Smith AL, Miller LW, Weiss LT, Kirklin JK; and the Cardiac Transplant Research Database (CTRD). Outcomes with hepatitis C following cardiac transplantation: a multi-institutional study. J Heart Lung Transplant. 1999;18:81. Abstract.
176. Tzakis AG, Cooper MH, Dummer JS, Ragni M, Ward JW, Starzl TE. Transplantation in HIV+ patients. Transplantation. 1990;49:354-358.
177. Gow PJ, Pillay D, Mutimer D. Solid organ transplantation in patients with HIV infection. Transplantation. 2001;72:177-181.
178. Kuo PC, Stock PG. Transplantation in the HIV+ patient. Am J Transplant. 2001;1:13-17.
179. Calabrese LH, Albrecht M, Young J, McCarthy P, Haug M, Jarcho J, Zackin R. Successful cardiac transplantation in an HIV-1-infected patient with advanced disease. N Engl J Med. 2003;348:2323-2328.
180. Huang J, Trinkaus K, Huddleston CB, Mendeloff EN, Spray TL, Canter CE. Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics. J Heart Lung Transplant. 2004;23:716-722.
181. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 1988;7:331-336.
182. Bourge RC, Naftel DC, Costanzo-Nordin MR, Kirklin JK, Young JB, Kubo SH, Olivari MT, Kasper EK; the Transplant Cardiologists Research Database Group. Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. J Heart Lung Transplant. 1993;12:549-562.
183. Bando K, Konishi H, Komatsu K, Fricker FJ, del Nido PJ, Francalancia NA, Hardesty RL, Griffith BP, Armitage JM. Improved survival following pediatric cardiac transplantation in high-risk patients. Circulation. 1993;88(pt 2):II-218-II-223.
184. Murali S, Kormos RL, Uretsky BF, Schechter D, Reddy PS, Denys BG, Armitage JM, Hardesty RL, Griffith BP. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J. 1993;126:896-904.
185. Zales VR, Pahl E, Backer CL, Crawford S, Mavroudis C, Benson DW Jr. Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation. J Heart Lung Transplant. 1993;12:965-973.
186. Gajarski RJ, Towbin JA, Bricker JT, Radovancevic B, Frazier OH, Price JK, Schowengerdt KO, Denfield SW. Intermediate follow-up of pediatric heart transplant recipients with elevated pulmonary vascular resistance index. J Am Coll Cardiol. 1994;23(pt 1):1682-1687.
187. Adatia I, Perry S, Landzberg M, Moore P, Thompson JE, Wessel DL. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol. 1995;25:1656-1664.
188. Hughes ML, Kleinert S, Keogh A, Macdonald P, Wilkinson JL, Weintraub RG. Pulmonary vascular resistance and reactivity in children with end-stage cardiomyopathy. J Heart Lung Transplant. 2000;19:701-704.
189. Kao B, Balzer DT, Huddleston CB, Canter CE. Long-term prostacyclin infusion to reduce pulmonary hypertension in a pediatric cardiac transplant candidate prior to transplantation. J Heart Lung Transplant. 2001;20:785-788.
190. Ofori-Amanfo, Hsu D, Lamour JM, Mital S, O'Byrne ML, Smerling AJ, Chen JM, Mosca R, Addonizio LJ. Heart transplantation in children with markedly elevated pulmonary vascular resistance. J Heart Lung Transplant. 2006;25:S49. Abstract.
191. Cochrane AD, Adams DH, Radley-Smith R, Khaghani A, Yacoub MH. Heterotopic heart transplantation for elevated pulmonary vascular resistance in pediatric patients. J Heart Lung Transplant. 1995;14:296-301.
192. Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study. Circulation. 2005;111:3274-3280.
193. Apostolopoulou SC, Manginas A, Cokkinos DV, Rammos S. Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease. Heart. 2005;91:1447-1452.
194. Perez-Villa F, Cuppoletti A, Rossel V, Vallejos I, Roig E. Initial experience with bosentan therapy in patients considered ineligible for heart transplantation because of severe pulmonary hypertension. Clin Transplant. 2006;20:239-244.
195. Salzberg SP, Lachat ML, von Harbou K, Zund G, Turina MI. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg. 2005;27:222-225.
196. Haddad H, Elabbassi W, Moustafa S, Davies R, Mesana T, Hendry P, Masters R, Mussivand T. Left ventricular assist device as bridge to heart transplantation in congestive heart failure with pulmonary hypertension. ASAIO J. 2005;51:456-460.
197. Blume ED, Naftel DC, Bastardi HJ, Duncan BW, Kirklin JK, Webber SA; Pediatric Heart Transplant Study Investigators. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation. 2006;113:2313-2319.
198. Baldwin JT, Borovetz HS, Duncan BW, Gartner MJ, Jarvik RK, Weiss WJ, Hoke TR. The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program. Circulation. 2006;113:147-155.
199. Miller LW, Kubo SH, Young JB, Stevenson LW, Loh E, Constanzo MR. Report of consensus conference on candidate selection for heart transplantation: 1993. J Heart Lung Transplant. 1995;14:562-571.
200. Paris W, Muchmore J, Pribil A, Zuhdi N, Cooper DK. Study of the relative incidences of psychosocial factors before and after heart transplantation and the influence of posttransplantation psychosocial factors on heart transplantation outcome. J Heart Lung Transplant. 1994;13:424-430.
201. Shapiro PA, Williams DL, Foray AT, Gelman IS, Wukich N, Sciacca R. Psychosocial evaluation and prediction of compliance problems and morbidity after heart transplantation. Transplantation. 1995;60:1462-1466.
202. Dew MA, Kormos RL, Roth LH, Murali S, DiMartini A, Griffith BP. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant. 1999;18:549-562.
203. Dobbels F, De Geest S, van Cleemput J, Droogne W, Vanhaecke J. Effect of late medication non-compliance on outcome after heart transplantation: a 5-year follow-up. J Heart Lung Transplant. 2004;23:1245-1251.
204. Serrano-Ikkos E, Lask B, Whitehead B, Eisler I. Incomplete adherence after pediatric heart and heart-lung transplantation. J Heart Lung Transplant. 1998;17:1177-1183.
205. Ringewald JM, Gidding SS, Crawford SE, Backer CL, Mavroudis C, Pahl E. Nonadherence is associated with late rejection in pediatric heart transplant recipients. J Pediatr. 2001;139:75-78.
206. Ikle L, Hale K, Fashaw L, Boucek M, Rosenberg AA. Developmental outcome of patients with hypoplastic left heart syndrome treated with heart transplantation. J Pediatr. 2003;142:20-25.
207. Wray J, Radley-Smith R. Beyond the first year after pediatric heart or heart-lung transplantation: changes in cognitive function and behaviour. Pediatr Transplant. 2005;9:170-177.
208. Wray J, Radley-Smith R. Developmental and behavioral status of infants and young children awaiting heart or heart-lung transplantation. Pediatrics. 2004;113(pt 1):488-495.
209. Fricker FJ, Addonizio L, Bernstein D, Boucek M, Boucek R, Canter C, Chinnock R, Chin C, Kichuk M, Lamour J, Pietra B, Morrow R, Rotundo K, Shaddy R, Schuette EP, Schowengerdt KO, Sondheimer H, Webber S. Heart transplantation in children: indications: report of the Ad Hoc Committee of the Pediatric Committee of the American Society of Transplantation (AST). Pediatr Transplant. 1999;3:333-342.
210. Webb N, Herbert D, Arbus G. Renal replacement therapy in Down's syndrome. Pediatr Nephrol. 1993;7:771.
211. Edvardsson VO, Kaiser BA, Polinsky MS, Baluarte HJ. Successful living-related renal transplantation in an adolescent with Down syndrome. Pediatr Nephrol. 1995;9:398-399.
212. Rubin CM, Mick R, Johnson FL. Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome. Bone Marrow Transplant. 1996;18:533-540.
213. Leonard H, Eastham K, Dark J. Heart and heart-lung transplantation in Down's syndrome: the lack of supportive evidence means each case must be carefully assessed. BMJ. 2000;320:816-817.